Report: Two Top Vaccine Regulators to Leave US FDA


On Tuesday, 31st September 2021, the US FDA said, two of the top vaccine regulators of the US FDA are now planning to leave the agency in the upcoming months, and Stephanie Caccomo, spokesperson for the US FDA said, the FDA has been very confident in the ability and expertise of their staff for the purpose of continuing their critical work related to the health of the people, which also includes the evaluation of the novel corona virus vaccines.

According to Peter Mark, director of Center for Biologics Evaluation and Research (CBER) said, Dr. Marion gruber, director of Office of Vaccines Research and review (OVRR) of FDA, has now been planning to retire in the upcoming months, and Marion Gruber had also been working with the FDA for 32 years, and Dr. Philip Krause, deputy of Dr. Marion Gruber, is also planning to leave the US FDA in the month of November 2021.

READ  US CDC Awards $215-Million As Part Of Revival Of Cancer Moonshot Initiative

He also said, he is going to be serving as the acting director of the novel corona virus vaccines group, while the US FDA have been searching for the next director of the US FDA, and this search process is going to start immediately.

Janet Woodcock, acting commissioner of US FDA said, they have put together a plan, that is going to be allowing them to continue the prioritization of the science, along with meeting the timelines, which have been very important to make sure the end of the devastating novel corona virus pandemic across the United States.